Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nika Furey

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
JHEP Reports : Innovation in Hepatology|February 11, 2020
Using CRISPR/Cas9 to model human liver diseaseMichele Alves-Bezerra, Nika Furey, Collin G Johnson, et al.
Current Protocols in Molecular Biology|March 10, 2020
Somatic Liver Knockout (SLiK): A Quick and Efficient Way to Generate Liver-Specific Knockout Mice Using Multiplex CRISPR/Cas9 Gene EditingCollin G Johnson, Tong Chen, Nika Furey, et al.
Antibiotics (Basel, Switzerland)|April 30, 2021
Antibacterial Mechanisms and Efficacy of Sarecycline in Animal Models of Infection and InflammationChristopher G Bunick, Jonette Keri, S Ken Tanaka, et al.
JHEP Reports : Innovation in Hepatology|March 18, 2021
A hepatitis B virus transgenic mouse model with a conditional, recombinant, episomal genomeRobert L Kruse, Mercedes Barzi, Xavier Legras, et al.
JHEP Reports : Innovation in Hepatology|April 11, 2025
CRISPR/Cas9 gene therapy increases the risk of tumorigenesis in the mouse model of hereditary tyrosinemia type ITong Chen, Mercedes Barzi, Nika Furey, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
JHEP Reports : Innovation in Hepatology|February 11, 2020
Using CRISPR/Cas9 to model human liver diseaseMichele Alves-Bezerra, Nika Furey, Collin G Johnson, et al.
Current Protocols in Molecular Biology|March 10, 2020
Somatic Liver Knockout (SLiK): A Quick and Efficient Way to Generate Liver-Specific Knockout Mice Using Multiplex CRISPR/Cas9 Gene EditingCollin G Johnson, Tong Chen, Nika Furey, et al.
Antibiotics (Basel, Switzerland)|April 30, 2021
Antibacterial Mechanisms and Efficacy of Sarecycline in Animal Models of Infection and InflammationChristopher G Bunick, Jonette Keri, S Ken Tanaka, et al.
JHEP Reports : Innovation in Hepatology|March 18, 2021
A hepatitis B virus transgenic mouse model with a conditional, recombinant, episomal genomeRobert L Kruse, Mercedes Barzi, Xavier Legras, et al.
JHEP Reports : Innovation in Hepatology|April 11, 2025
CRISPR/Cas9 gene therapy increases the risk of tumorigenesis in the mouse model of hereditary tyrosinemia type ITong Chen, Mercedes Barzi, Nika Furey, et al.
Pageof 1